DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Schiff MH, Burmester GR, Kent JM, Pangan AL, Kupper H, Fitzpatrick SB, Donovan C.
Safety analyses of adalimumab (Humira) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.
Ann Rheum Dis 2006; 65: 889-894
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.